Table 2.
The correlation between load of HPV 16 DNA in primary focus and clinical and histopathological features.
| Characteristics | n | Ct ( ) | P | logcopies ( ) | P |
|---|---|---|---|---|---|
| Age (years) | |||||
| < 40 | 6 | 23.37 ± 3.48 | 0.281 | 5.88 ± 0.94 | 0.287 |
| ≥ 40 | 11 | 25.61 ± 4.18 | 5.33 ± 1.00 | ||
| Clinical stage | |||||
| I | 13 | 23.95 ± 2.31 | 0.107 | 5.77 ± 0.62 | 0.065 |
| II | 4 | 27.64 ± 7.05 | 4.74 ± 1.59 | ||
| Tumor diameter (cm) | |||||
| < 4 | 10 | 26.47 ± 3.93 | 0.036* | 5.13 ± 1.00 | 0.044* |
| ≥ 4 | 7 | 22.46 ± 2.87 | 6.09 ± 0.68 | ||
| Tumor differentiation | |||||
| Poor differentiated | 5 | 24.82 ± 1.28 | 0.999 | 5.39 ± 0.52 | 0.727 |
| Moderately** | 12 | 24.82 ± 4.75 | 5.58 ± 1.14 | ||
| Histological type | |||||
| SC | 15 | 25.05 ± 4.17 | 0.535 | 5.51 ± 1.03 | 0.895 |
| AC | 2 | 23.11 ± 2.16 | 5.62 ± 0.83 | ||
| Depth of myometrial invasion | |||||
| < 2/3 | 9 | 24.88 ± 1.58 | 0.948 | 5.47 ± 0.45 | 0.809 |
| ≥ 2/3 | 8 | 24.75 ± 5.79 | 5.59 ± 1.40 | ||
| Lymph nodes metastasis | |||||
| No | 12 | 23.97 ± 3.05 | 0.182 | 5.68 ± 0.84 | 0.341 |
| Yes | 5 | 26.86 ± 5.55 | 5.16 ± 1.30 | ||
| No. of excision lymph nodes | |||||
| < 20 | 11 | 24.76 ± 4.92 | 0.935 | 5.46 ± 1.17 | 0.744 |
| ≥ 20 | 6 | 24.93 ± 1.57 | 5.64 ± 0.57 | ||